Cantor Fitzgerald and Eli Lilly and Company were mentioned in a recent report with no specific relationship found.
1 report, 1 independent
Updated Jun 18
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Cantor Fitzgerald and Eli Lilly and Company were mentioned in a recent report with no specific relationship found.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Morgan Stanley and Capital Research Global Investors lifted their positions in Eli Lilly, while Cantor Fitzgerald provided new research reports on the stock.Sub-event
No specific action or relationship was found between the two companies.1 source
Keep exploring
The entities involved
-
Cantor Fitzgerald
American financial services company
-
Eli Lilly and Company
American pharmaceutical company
Related events
- Cantor Fitzgerald provided research reports on Cabaletta Bio, a company whose stock trades on Nasdaq.
- Howard Lutnick served as Chairman and CEO of Cantor Fitzgerald.
- Both Cantor Fitzgerald and Oppenheimer Holdings began covering Five Below stock.
- Cantor Fitzgerald affiliates organized a Special Purpose Acquisition Company (SPAC).